Diabetic foot has become one of the most challenging and complex problems in the medical world, and for good reason. Healing a diabetic wound requires the synchronized collaboration of over 30 different medical functions, much like a philharmonic orchestra.
Driven by the immense challenges and inadequate solutions in diabetic foot treatment, TriO was born. The company has developed a revolutionary solution – a groundbreaking device that combines all the necessary actions for treating diabetic foot simultaneously. The device is easy to operate and can be used by any caregiver or family member at the optimal time for healing. Implementing it as a treatment protocol for DFU (Diabetic foot ulcer) patients can significantly change the lives of over 537 million people with diabetes worldwide prevent amputation and save lives. The innovative device provides accessible, user-friendly, and affordable treatment using built-in AI control
Our Vision
To fundamentally change medical care and significantly reduce physical and emotional suffering for DFU patients worldwide.
Our Mission
To enable DFU's patients to be treated at home and in clinics with an innovative, effective and affordable medical solution that will improve their health at the most critical stages of healing.
The Key Advantages that Open the Door
to a Worldwide Change
From a ticking time bomb that robs DFU patients of their will to live, to a solution available in every home and local clinic.
Addressing a major medical challenge, our solution
is a breakthrough that offers a paradigm shift in the treatment
of Diabetic Foot Ulcers (DFU).
Potentially saving
billions of dollars for
global healthcare systems
by reducing hospitalization
costs and associated
medical procedures
related to DFU
User-friendly and affordable, it can be used in clinics or at home, enabling treatment
at a much earlier stage of
wound development.
FITT Treats DFU using 3 distinct methods for improved outcomes and treatment cost savings:
Compression therapy - evacuates the edema from the ulcer
Negative Pressure - increases blood flow to the ulcer
Disinfection with Ozone
Prevents unnecessary amputations and the psychological trauma, significantly improving the quality and life expectancy of patients.
A comprehensive solution
that includes digital applications, machine learning using AI, and a monitoring app to implement optimal clinical regimen and adjust the protocol based on collected data.
FITT gives Diabetes patients and their caregivers control over their treatment, reducing both the immense physical and psychological trauma caused by diabetic ulcers.
Our Story
"We love people more for the good we have done them than for the good they have done us."
Leo Tolstoy
The three founders of the project, leading experts in their field, made it their mission driven by a desire to act. A combination of professional curiosity, personal experience with the phenomenon, and a desire to bring something good into the world brought together the key players in this important medical project.
Join Us in Revolutionizing
DFU Treatment Worldwide
The Global Diabetes Epidemic:
-
Over 537 million people currently live with diabetes worldwide.
-
This number is expected to reach 700 million by 2045.
-
25% of people with diabetes will develop DFU, with a 5-year mortality rate of 42%.
-
More than half of DFU patients will develop an infection, leading to 17% undergoing amputation as a treatment.
-
Fear of amputation is greater than fear of death for most diabetic foot patients.
-
The global cost of diabetes in 2015 was estimated at $1.3 trillion.
-
Nearly one-third of direct diabetes costs are attributed to DFU treatment.
